CSL's Gene Therapy Approval Marks First for Hemophilia B and New High in Pricing
6 days ago - By MedCity News
CSL Behring's hemophilia B gene therapy, Hemgenix, carries a $3.5 million list price. But the company contends that by reducing economic burdens associated with bleeding and prophylactic infusions, the one-time treatment will save money over time.
Read more ...
The headlines of Care Mag
Michael Pertschuk, Antismoking and Auto Safety Crusader, Dies at 89
As an obscure but muscular congressional staffer and chairman of the Federal Trade Commission, he helped usher into law a raft of consumer protections.
Tiny Love Stories: ‘The Only Way I'll Meet a Man'
Modern Love in miniature, featuring reader-submitted stories of no more than 100 words.
Ex-hospital CEO Sues MetroHealth for Alleged Illegal Firing
Dr. Akram Boutros said in a lawsuit filed Monday in Cuyahoga County court that Cleveland-based MetroHealth's board of directors violated open meeting laws when it “secretly...
Juice Is Just The Start: 12 More Things You Can Make In A Nama J2 Juicer
Single-use appliance, who?
The 9 Best Luxury Mattresses For A Sleep You've Only Dreamed About
For a sleep you've only dreamt about.
This Hack Is the Best Shortcut to "Indie Sleaze" Lashes
Before I was a beauty editor , I was just a girl who was obsessed with all things makeup. Aside from a hefty cosmetics collection, this obsession resulted in an incessant need...
The Mistake Fitness Experts Say People Make With The 12-3-30 Treadmill Workout
The 12-3-30 workout is effective-but it's not magic.
Brain Cells Start To Die In Your 20s: How To Keep Your Mind Sharp As You Age
Neuroscientists and psychologists share their favorite games for keeping the mind young.
Barcodes Are Us
BY KIM BELLARD Usually I write about things where I see some unexpected parallel to healthcare, or something just amazed me, or outraged me (there are lots of things about...
STAT+: Horizon Therapeutics in acquisition talks with Amgen, Janssen, and Sanofi
Amgen, Janssen, and Sanofi are in talks to acquire Horizon Therapeutics, the Irish drugmaker confirmed Monday. Horizon confirmed the discussions following a report in the Wall...